🇺🇸 FDA
Pipeline program

CEA-targeted CAR-T cells

PBC101

Phase 1 mab active

Quick answer

CEA-targeted CAR-T cells for Peritoneal Metastases From Colorectal Cancer is a Phase 1 program (mab) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Peritoneal Metastases From Colorectal Cancer
Phase
Phase 1
Modality
mab
Status
active

Clinical trials